Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Ramos

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Transplantation and Cellular Therapy|January 24, 2022
Should CD19 CAR-T Cells for ALL be Followed by Allogeneic Stem Cell Transplant?Carlos A Ramos
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2012
Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemiaCarlos A Ramos
The American Journal of Clinical Hypnosis|May 6, 2026
Relational hypnotherapy, lucid dreaming, and sleep paralysis: A case studyCarlos A Ramos
Expert Opinion on Biological Therapy|April 6, 2011
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapyCarlos A Ramos, Gianpietro Dotti
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" TherapyPremal Lulla, Carlos A Ramos
Current Treatment Options in Oncology|February 13, 2020
Cellular Immunotherapy in Lymphoma: Beyond CART CellsMahmoud R Gaballa, Carlos A Ramos
Biotechnology Journal|September 30, 2017
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly LineDiogo Gomes-Silva, Carlos A Ramos
Blood Advances|February 13, 2024
CARs for Hodgkin: engine fine-tuning is in orderNatalie S Grover, Carlos A Ramos
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CD19-CAR trialsCarlos A Ramos, Barbara Savoldo, Gianpietro Dotti
Current Opinion in Hematology|March 29, 2006
Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissueHans-Georg Kopp, Carlos A Ramos, Shahin Rafii
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|January 24, 2022
Should CD19 CAR-T Cells for ALL be Followed by Allogeneic Stem Cell Transplant?Carlos A Ramos
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2012
Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemiaCarlos A Ramos
The American Journal of Clinical Hypnosis|May 6, 2026
Relational hypnotherapy, lucid dreaming, and sleep paralysis: A case studyCarlos A Ramos
Expert Opinion on Biological Therapy|April 6, 2011
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapyCarlos A Ramos, Gianpietro Dotti
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" TherapyPremal Lulla, Carlos A Ramos
Current Treatment Options in Oncology|February 13, 2020
Cellular Immunotherapy in Lymphoma: Beyond CART CellsMahmoud R Gaballa, Carlos A Ramos
Biotechnology Journal|September 30, 2017
Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly LineDiogo Gomes-Silva, Carlos A Ramos
Blood Advances|February 13, 2024
CARs for Hodgkin: engine fine-tuning is in orderNatalie S Grover, Carlos A Ramos
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CD19-CAR trialsCarlos A Ramos, Barbara Savoldo, Gianpietro Dotti
Current Opinion in Hematology|March 29, 2006
Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissueHans-Georg Kopp, Carlos A Ramos, Shahin Rafii
Pageof 8